Prognostic Accuracy of NEDA-3 in Long-term Outcomes of Multiple Sclerosis.

This study provides Class II evidence that in patients with RRMS who attained NEDA-3 status, subsequent RAW was associated with baseline MRI activity and discontinuation of treatment and PIRA was associated with age and the presence of baseline spinal cord lesions.